FeesSafety
Pluang+

Japan approves and launches BRINSUPRI, the first oral treatment for non-cystic fibrosis bronchiectasis (NCFB).

Others
19 Oct 2026, 14:00 WIB
PRNewsWire
View Source
Bullish
Japan approves and launches BRINSUPRI, the first oral treatment for non-cystic fibrosis bronchiectasis (NCFB).

Insmed has launched BRINSUPRI Tablets 25 mg in Japan, the first approved oral treatment specifically for non-cystic fibrosis bronchiectasis (NCFB). Approved by Japan's Ministry of Health in August 2026, BRINSUPRI targets the underlying inflammation in NCFB, offering a new option for patients aged 12 and older. This launch marks a significant advancement in managing this chronic lung disease, which causes frequent respiratory infections and lung damage. Insmed aims to support better disease control and patient outcomes in Japan with this therapy.

The launch of BRINSUPRI Tablets 25 mg for non-cystic fibrosis bronchiectasis in Japan provides new treatment options for chronic lung disease. For readers following the health sector, here is Pluang's market snapshot as of Oct 19, 2026 17:11 WIB: Among 150 priced US health stocks, 69 rose and 45 fell today. Notable movers include RXRX at USD 3.54 with a 1-day change of +2.16% and a typical hold time of 21 days, AMLX at USD 26.86 with +1.97% change and 16 days hold, and NUWE at USD 0.56 with +1.95% change and 28 days hold.

More News

Monday.com expands AI platform; Okta leads in identity security with strong 2026 results.

Monday.com expands AI platform; Okta leads in identity security with strong 2026 results.

Monday.com is growing its AI-driven platform beyond work management into CRM and software development, achieving 22.4% revenue growth and nearly $1.4 billion in revenue for the year ending September 2026. Okta, a leader in identity security, serves o...

Market News
Neutral
22 minutes ago
Invest long-term and avoid market timing to maximize returns, inspired by Wayne Gretzky's advice.

Invest long-term and avoid market timing to maximize returns, inspired by Wayne Gretzky's advice.

Warren Buffett highlights Wayne Gretzky's famous advice, "Skate to where the puck is going to be," as a key investing lesson: focus on the future and stay invested long-term. Fidelity research shows missing the five best days in the S&P 500 from 1987...

Market News
Bullish
40 minutes ago
New AI tool checks stock filings for hidden warning signs to aid investors' decisions.

New AI tool checks stock filings for hidden warning signs to aid investors' decisions.

A new AI-powered prompt helps investors identify warning signs in company filings by scanning for issues like auditor doubts, insider sales, and leadership changes. It highlights items worth closer inspection without giving investment advice, using r...

Market News
Bearish
40 minutes ago
Netflix's stock drops nearly 47% but remains profitable with growth potential over five years.

Netflix's stock drops nearly 47% but remains profitable with growth potential over five years.

Netflix's shares have fallen nearly 47% from their 52-week high, reflecting concerns about slowing revenue growth and increased competition. Despite this, Netflix remains highly profitable, with rising operating margins and expected revenue growth of...

Market News
Neutral
55 minutes ago
Tesla ends Cybertruck production, boosting Rivian's chance to capture electric truck buyers.

Tesla ends Cybertruck production, boosting Rivian's chance to capture electric truck buyers.

Tesla is ending production of its Cybertruck to focus on other projects, leading to increased demand for alternative electric trucks. Rivian, with its newly launched lower-cost R2 model, is well-positioned to attract former Cybertruck customers. This...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App